X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7294) 7294
Book Review (842) 842
Publication (624) 624
Newsletter (59) 59
Newspaper Article (16) 16
Data Set (14) 14
Dissertation (9) 9
Book / eBook (4) 4
Book Chapter (4) 4
Conference Proceeding (4) 4
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6756) 6756
glucose (4565) 4565
humans (4079) 4079
medicine (3505) 3505
research article (3376) 3376
animals (3358) 3358
male (3321) 3321
multidisciplinary sciences (3317) 3317
science (3147) 3147
diabetes (3121) 3121
metabolism (2951) 2951
insulin (2622) 2622
female (2602) 2602
rodents (2323) 2323
diabetes mellitus (2286) 2286
insulin resistance (2232) 2232
metabolic disorders (1957) 1957
mice (1926) 1926
obesity (1926) 1926
proteins (1841) 1841
biochemistry (1827) 1827
endocrinology (1646) 1646
dextrose (1614) 1614
glucose metabolism (1614) 1614
medicine and health sciences (1576) 1576
research (1563) 1563
biology and life sciences (1562) 1562
physiological aspects (1497) 1497
type 2 diabetes (1464) 1464
gene expression (1459) 1459
adult (1447) 1447
middle aged (1430) 1430
physiology (1363) 1363
risk factors (1356) 1356
studies (1287) 1287
analysis (1257) 1257
biology (1246) 1246
cell biology (1236) 1236
health aspects (1193) 1193
rats (1181) 1181
kinases (1120) 1120
lipids (1119) 1119
homeostasis (1039) 1039
glucose - metabolism (1012) 1012
insulin-resistance (1001) 1001
inflammation (984) 984
body weight (980) 980
oxidative stress (973) 973
liver (972) 972
diabetic endocrinology (962) 962
blood glucose - metabolism (925) 925
diet (881) 881
hyperglycemia (876) 876
signal transduction (874) 874
metabolic syndrome (859) 859
aged (806) 806
nutrition (796) 796
cholesterol (791) 791
medical research (790) 790
apoptosis (760) 760
glucose tolerance (753) 753
biochemistry & molecular biology (738) 738
hormones (726) 726
blood (718) 718
animal models (712) 712
fatty acids (708) 708
body mass index (693) 693
expression (688) 688
enzymes (683) 683
genetic aspects (675) 675
patients (666) 666
fasting (644) 644
brain (636) 636
phosphorylation (632) 632
care and treatment (626) 626
anatomy (623) 623
cardiovascular disease (618) 618
adipose tissue (616) 616
immunology (608) 608
physical sciences (605) 605
genetics (601) 601
genes (598) 598
laboratories (598) 598
hypertension (596) 596
mice, inbred c57bl (595) 595
lipid metabolism (588) 588
health risks (583) 583
research and analysis methods (583) 583
life sciences (577) 577
disease (573) 573
insulin - metabolism (560) 560
hospitals (548) 548
blood pressure (546) 546
risk (546) 546
pharmacology (539) 539
activation (535) 535
triglycerides (529) 529
neurosciences (525) 525
body mass (518) 518
metabolites (518) 518
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Infectious Diseases, ISSN 1201-9712, 2014, Volume 23, pp. 75 - 81
Summary Background Insulin resistance is highly prevalent in patients with chronic hepatitis C (CHC) and to some extent accounts for fibrosis and reducing... 
Infectious Disease | Pulmonary/Respiratory | Cannabinoid 1 receptor | Hepatitis C virus | Endocannabinoids | Hepatic glucose metabolism | CB1R | INFECTIOUS DISEASES | BOUND TRANSCRIPTION FACTOR | CREBH | INHIBITION | GLUCONEOGENESIS | INSULIN-RESISTANCE | LIVER | MICE | CANNABINOIDS | CB1 RECEPTORS | Endocannabinoids - metabolism | Glucose Transporter Type 2 - genetics | Glucose-6-Phosphatase - genetics | Up-Regulation | AMP-Activated Protein Kinases - metabolism | Hepatitis C, Chronic - pathology | Phosphorylation | Coculture Techniques | Humans | Hepatocytes - metabolism | RNA, Messenger - metabolism | Glucose Transporter Type 2 - metabolism | Arachidonic Acids - metabolism | Piperidines - pharmacology | Hepacivirus - physiology | Hepatic Stellate Cells - virology | Glucose Metabolism Disorders - virology | RNA, Viral - isolation & purification | Real-Time Polymerase Chain Reaction | Hepatic Stellate Cells - pathology | Glucose Metabolism Disorders - pathology | Pyrazoles - pharmacology | Cell Line | Genome, Viral | Hepacivirus - isolation & purification | Signal Transduction | Cell Survival | RNA, Messenger - genetics | Glycerides - metabolism | Polyunsaturated Alkamides - metabolism | Arachidonic Acids - pharmacology | Glucose-6-Phosphatase - metabolism | Cyclic AMP Response Element-Binding Protein - genetics | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB1 - genetics | Virus Replication | Cyclic AMP Response Element-Binding Protein - metabolism | Hepatocytes - virology | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | AMP-Activated Protein Kinases - genetics | Virus diseases | Glucose metabolism | Physiological aspects | Insulin resistance | Glucose | Dextrose | Index Medicus
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 01/2014, Volume 26, Issue 1, pp. 52 - 58
Journal Article
Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, ISSN 1003-9279, 12/2003, Volume 17, Issue 4, p. 372
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 149, Issue 6, pp. 1345 - 1360
Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic manifestations. Patients with HCV may develop mixed cryoglobulinemia and its... 
Gastroenterology and Hepatology | Fatigue | Cryoglobulins | Cardiovascular Risk | Health-Related Quality of Life | Insulin Resistance | PORPHYRIA-CUTANEA-TARDA | MIXED CRYOGLOBULINEMIA VASCULITIS | PATIENT-REPORTED OUTCOMES | SUSTAINED VIROLOGICAL RESPONSE | MAGNETIC-RESONANCE-SPECTROSCOPY | POPULATION-BASED COHORT | ALPHA-2A PLUS RIBAVIRIN | QUALITY-OF-LIFE | CHRONIC HCV INFECTION | IDIOPATHIC PULMONARY-FIBROSIS | GASTROENTEROLOGY & HEPATOLOGY | Interferon-alpha - pharmacology | Vasculitis - epidemiology | Humans | Hepatitis C, Chronic - virology | Hepacivirus - pathogenicity | Vasculitis - virology | Cryoglobulinemia - virology | Hepatitis C, Chronic - mortality | Cryoglobulinemia - epidemiology | Glucose Metabolism Disorders - virology | Hepatitis C, Chronic - epidemiology | Glomerulonephritis - epidemiology | Hepacivirus - drug effects | Lymphoma - epidemiology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Glomerulonephritis - virology | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Morbidity | Hepatitis C, Chronic - immunology | Glucose Metabolism Disorders - epidemiology | Ribavirin - pharmacology | Lymphoma - virology | Medical colleges | Patient outcomes | Liver | Mortality | Atherosclerosis | Insulin resistance | Lymphomas | Hepatitis C | Biological response modifiers | Hepatitis C virus | Index Medicus | Abridged Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, pp. e98032 - e98032
Severe influenza is characterized by cytokine storm and multiorgan failure with metabolic energy disorders and vascular hyperpermeability. In the regulation of... 
A VIRUS | RAT LUNGS | PROTEIN-KINASE | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | TRYPSIN-I | PROLIFERATOR-ACTIVATED RECEPTOR | IDENTIFICATION | BLOOD-BRAIN-BARRIER | CARNITINE PALMITOYLTRANSFERASE-II | Protein Kinases - metabolism | Metabolic Diseases - enzymology | Orthomyxoviridae Infections - complications | Metabolic Diseases - drug therapy | Orthomyxoviridae Infections - enzymology | Pyruvic Acid - metabolism | Female | Phosphorylation - drug effects | Real-Time Polymerase Chain Reaction | Enzyme-Linked Immunosorbent Assay | Oxidation-Reduction | Mice, Inbred C57BL | Quaternary Ammonium Compounds - therapeutic use | RNA, Messenger - genetics | Influenza A Virus, H1N1 Subtype - pathogenicity | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Animals | Metabolic Diseases - etiology | Protein Kinase Inhibitors - therapeutic use | Multiple Organ Failure - etiology | Lipid Metabolism - drug effects | Multiple Organ Failure - enzymology | Glucose - metabolism | Mice | Orthomyxoviridae Infections - virology | Multiple Organ Failure - drug therapy | Glucose metabolism | Synthesis | Cytokines | Influenza | Liver | Physiological aspects | Muscles | Glucose | Health aspects | Fatty acids | Dextrose | Heart | Tricarboxylic acid cycle | Regulations | Energy metabolism | Dichloroacetic acid | Dehydrogenases | Disorders | Dehydrogenase | Lipid metabolism | Failure | Enzymes | Pathogens | Cardiac muscle | Gene expression | Metabolism | Energy balance | Chemistry | Inhibitors | Metabolic disorders | Homeostasis | Pyruvic acid | Viruses | Lipids | Infections | Kinases | Energy | Metabolites | Rodents | Influenza A | Tumor necrosis factor-TNF | Edema | Research & development--R&D | Oral administration | Organs | Pharmacology | Chemical compounds | Skeletal muscle | Trypsin | Brain research | Storms | Lungs | Decarboxylation | Glycolysis | Diabetes | Laboratory animals | ATP | Index Medicus | Research & development | R&D
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, pp. e0122373 - e0122373
Hepatitis B virus (HBV) pre-S2 mutant can induce hepatocellular carcinoma (HCC) via the induction of endoplasmic reticulum stress to activate mammalian target... 
HEPATOCELLULAR-CARCINOMA | S MUTANTS | X-PROTEIN | GROUND-GLASS HEPATOCYTES | MULTIDISCIPLINARY SCIENCES | C-MYC | TISSUE METABOLOMICS | CANCER-CELL METABOLISM | EXPRESSION | MTOR | TRANSGENIC MICE | Hepatitis B Surface Antigens - genetics | Immunohistochemistry | Hepatitis B - metabolism | TOR Serine-Threonine Kinases - metabolism | Humans | Hepatitis B - virology | Glucose Transporter Type 1 - metabolism | YY1 Transcription Factor - metabolism | Phosphoproteins - metabolism | Liver Neoplasms - etiology | Glycogen - metabolism | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - etiology | Cell Line | Protein Precursors - genetics | Signal Transduction | Hepatitis B Surface Antigens - metabolism | Mice, Transgenic | Proto-Oncogene Proteins c-myc - metabolism | Protein Precursors - metabolism | Mutant Proteins | Animals | Carcinoma, Hepatocellular - pathology | Hepatitis B virus - genetics | Liver Neoplasms - metabolism | Glycolysis | Mice | Hepatitis B virus - metabolism | Adaptor Proteins, Signal Transducing - metabolism | Carcinoma, Hepatocellular - metabolism | Glycogen | Development and progression | Rapamycin | Glucose | Gene expression | Dextrose | Infection | Lactates | Glucose metabolism | Analysis | Resveratrol | Genetic engineering | Hepatitis B virus | Health aspects | Protein binding | Hepatitis B | TOR protein | Metabolic rate | Chronic infection | Viruses | Hepatocellular carcinoma | Activation | Myc protein | Hepatitis | Animal tissues | Tumorigenesis | Glucose transporter | Risk groups | Transgenic mice | Translation initiation | YY1 protein | Mammals | Metabolism | Signaling | Chemotherapy | Silymarin | Lactic acid | Aberration | Endoplasmic reticulum | Transporter | Metabolic disorders | Index Medicus
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 12/2011, Volume 58, Issue 4, pp. 371 - 378
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2017, Volume 12, Issue 1, pp. e0170240 - e0170240
Chronic hepatitis C has been associated with metabolic syndrome that includes insulin resistance, hepatic steatosis and obesity. These metabolic aberrations... 
PLUS RIBAVIRIN | HEPATOCELLULAR-CARCINOMA | STEATOSIS | INSULIN-RESISTANCE | MULTIDISCIPLINARY SCIENCES | HEPATITIS-C-VIRUS | LIVER-DAMAGE | B INFECTIONS | MODEL | CHRONIC HCV INFECTION | VIRAL-HEPATITIS | </